.svg){kind=small}
Oct-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Beard Bros Pharms has shown a consistent presence in the Tincture & Sublingual category in California, maintaining a steady rank of 21st for both July and August 2025. However, the absence of a ranking in September and October suggests a significant drop, indicating that they did not make it into the top 30 brands during these months. This could be seen as a negative movement, potentially reflecting a decline in consumer interest or increased competition within the category. Despite this, the brand's ability to maintain a stable position in the earlier months highlights their initial competitive stance in the California market.
In terms of sales, Beard Bros Pharms experienced a decrease from July to August, with sales figures dropping from $12,138 to $10,595. This downward trend in sales aligns with their eventual disappearance from the top 30 rankings in subsequent months. The lack of data for September and October doesn't allow for a comprehensive analysis of their performance during these months, but the initial decline in both rank and sales suggests challenges the brand may be facing in maintaining its market presence. Observing these trends could be crucial for understanding the dynamics of the Tincture & Sublingual category in California and assessing the brand's strategic adjustments moving forward.
Competitive Landscape
In the competitive landscape of California's Tincture & Sublingual category, Beard Bros Pharms has faced challenges in maintaining a top 20 rank from July to October 2025. Despite starting at rank 21 in July and August, the brand did not make it into the top 20 in September and October, indicating a need for strategic adjustments to regain market presence. Meanwhile, Kind Medicine consistently held a position within the top 20, maintaining rank 20 in September and October, which suggests a stable consumer base and effective market strategies. Additionally, Chemistry entered the top 20 in October, ranking at 21, which could indicate emerging competition for Beard Bros Pharms. These dynamics highlight the importance for Beard Bros Pharms to innovate and enhance their market strategies to improve their rank and sales in this competitive category.
Notable Products
In October 2025, Beard Bros Pharms saw its High THC Full Spectrum Oil Syringe (1g) maintain its top position as the best-selling product in the Concentrates category, with a significant increase in sales to 333 units. The THC/CBN 2:1 Nighttime Tincture (600mg THC, 300mg CBN, 1oz) improved its ranking from third in September to second in October, with notable sales of 124 units. The THC:CBD 20:1 HighTHC Spectrum Tincture (600mg THC, 30mg CBD, 30ml, 1oz) experienced a slight drop in ranking from second to third, despite a modest sales increase. The CBD/THC 10:1 High Full Spectrum Oil (1g) moved up to fourth place, showing an upward trend in sales since its debut in September. Additionally, the CBD/THC 1:1 Full Spectrum RSO Dablicator (1g) also secured the fourth spot in October, maintaining consistent sales figures.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
